Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 915343, 8 pages
http://dx.doi.org/10.1155/2013/915343
Research Article

A Network Pharmacology Approach to Evaluating the Efficacy of Chinese Medicine Using Genome-Wide Transcriptional Expression Data

1Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
2Chiatai Qingchunbao Pharmaceutical Co., Ltd., Hangzhou 310023, China

Received 18 December 2012; Revised 13 February 2013; Accepted 17 February 2013

Academic Editor: Lixing Lao

Copyright © 2013 Leihong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Normile, “The new face of traditional Chinese medicine,” Science, vol. 299, no. 5604, pp. 188–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. S. F. Nagueh, C. P. Appleton, T. C. Gillebert et al., “Recommendations for the evaluation of left ventricular diastolic function by echocardiography,” European Journal of Echocardiography, vol. 10, no. 2, pp. 165–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. F. Shariat, P. I. Karakiewicz, R. Ashfaq et al., “Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy,” Cancer, vol. 112, no. 2, pp. 315–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. A. Landers, M. J. Burger, M. A. Tebay et al., “Use of multiple biomarkers for a molecular diagnosis of prostate cancer,” International Journal of Cancer, vol. 114, no. 6, pp. 950–956, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. J. Kelloff and C. C. Sigman, “Cancer biomarkers: selecting the right drug for the right patient,” Nature Reviews Drug Discovery, vol. 11, no. 3, pp. 201–214, 2012. View at Publisher · View at Google Scholar
  6. L. M. Mangravite, C. F. Thorn, and R. M. Krauss, “Clinical implications of pharmacogenomics of statin treatment,” Pharmacogenomics Journal, vol. 6, no. 6, pp. 360–374, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Eichelbaum, M. Ingelman-Sundberg, and W. E. Evans, “Pharmacogenomics and individualized drug therapy,” Annual Review of Medicine, vol. 57, pp. 119–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Shi, L. H. Reid, W. D. Jones et al., “The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements,” Nature Biotechnology, vol. 24, no. 9, pp. 1151–1161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. T. R. Adib, S. Henderson, C. Perrett et al., “Predicting biomarkers for ovarian cancer using gene-expression microarrays,” British Journal of Cancer, vol. 90, no. 3, pp. 686–692, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Shao, X. Fan, N. Cheng et al., “Shifting from population-wide to personalized cancer prognosis with microarrays,” PLoS ONE, vol. 7, no. 1, Article ID e29534, 2012. View at Google Scholar
  11. L. Shi, G. Campbell, W. D. Jones et al., “The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models,” Nature Biotechnology, vol. 28, no. 8, pp. 827–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Fan, E. K. Lobenhofer, M. Chen et al., “Consistency of predictive signature genes and classifiers generated using different microarray platforms,” Pharmacogenomics Journal, vol. 10, no. 4, pp. 247–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Fan, L. Shi, H. Fang, Y. Cheng, R. Perkins, and W. Tong, “DNA microarrays are predictive of cancer prognosis: a re-evaluation,” Clinical Cancer Research, vol. 16, no. 2, pp. 629–636, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Shao, L. Wu, H. Fang, W. Tong, and X. Fan, “Does applicability domain exist in microarray-based genomic research?” PLoS ONE, vol. 5, no. 6, Article ID e11055, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Saeys, I. Inza, and P. Larrañaga, “A review of feature selection techniques in bioinformatics,” Bioinformatics, vol. 23, no. 19, pp. 2507–2517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Liu, A. Liberzon, S. W. Kong et al., “Network-based analysis of affected biological processes in type 2 diabetes models,” PLoS Genetics, vol. 3, no. 6, p. e96, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Nikolsky, T. Nikolskaya, and A. Bugrim, “Biological networks and analysis of experimental data in drug discovery,” Drug Discovery Today, vol. 10, no. 9, pp. 653–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. K. I. Goh, M. E. Cusick, D. Valle, B. Childs, M. Vidal, and A. L. Barabási, “The human disease network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 21, pp. 8685–8690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. F. Jonsson and P. A. Bates, “Global topological features of cancer proteins in the human interactome,” Bioinformatics, vol. 22, no. 18, pp. 2291–2297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Bebek, M. Koyuturk, N. D. Price, and M. R. Chance, “Network biology methods integrating biological data for translational science,” Briefings in Bioinformatics, vol. 13, no. 4, pp. 446–459, 2012. View at Publisher · View at Google Scholar
  21. S. E. Calvano, W. Xiao, D. R. Richards et al., “A network-based analysis of systemic inflammation in humans,” Nature, vol. 437, no. 7061, pp. 1032–1037, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Ideker, O. Ozier, B. Schwikowski, and A. F. Siegel, “Discovering regulatory and signalling circuits in molecular interaction networks,” Bioinformatics, vol. 18, no. 1, pp. S233–S240, 2002. View at Google Scholar · View at Scopus
  23. Y. Devaux, F. Azuaje, M. Vausort, C. Yvorra, and D. R. Wagner, “Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction,” Functional and Integrative Genomics, vol. 10, no. 3, pp. 329–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Y. Chuang, E. Lee, Y. T. Liu, D. Lee, and T. Ideker, “Network-based classification of breast cancer metastasis,” Molecular Systems Biology, vol. 3, article 140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Haijiang, W. Yongjiang, and C. Yiyu, “Analysis of 'SHENMAI' injection by HPLC/MS/MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 31, no. 1, pp. 175–183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Xiaohui, W. Yi, and C. Yiyu, “LC/MS fingerprinting of Shenmai injection: a novel approach to quality control of herbal medicines,” Journal of Pharmaceutical and Biomedical Analysis, vol. 40, no. 3, pp. 591–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Hu, W. Zhang, Y. Xie et al., “Meta-analysis of Shenmai injection treatment for acute myocardial infarction,” Zhong Guo Zhong Yao Za Zhi, vol. 37, no. 18, 2012. View at Google Scholar
  28. Chinese Pharmacopeia Commission, Pharmacopoeia of the People's Republic of China, China Medical Science Press, Beijing, China, 2010 edition, 2011.
  29. H. Fang, S. C. Harris, Z. Su et al., “ArrayTrack: an FDA and public genomic tool,” Methods in Molecular Biology, vol. 563, pp. 379–398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Ogata, S. Goto, K. Sato, W. Fujibuchi, H. Bono, and M. Kanehisa, “KEGG: Kyoto encyclopedia of genes and genomes,” Nucleic Acids Research, vol. 27, no. 1, pp. 29–34, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Stark, B. J. Breitkreutz, T. Reguly, L. Boucher, A. Breitkreutz, and M. Tyers, “BioGRID: a general repository for interaction datasets,” Nucleic Acids Research, vol. 34, no. database issue, pp. D535–D539, 2006. View at Google Scholar · View at Scopus
  32. T. S. Keshava Prasad, R. Goel, K. Kandasamy et al., “Human protein reference database—2009 update,” Nucleic Acids Research, vol. 37, no. 1, pp. D767–D772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. E. Smoot, K. Ono, J. Ruscheinski, P. L. Wang, and T. Ideker, “Cytoscape 2.8: new features for data integration and network visualization,” Bioinformatics, vol. 27, no. 3, pp. 431–432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. L. Barabási and Z. N. Oltvai, “Network biology: understanding the cell's functional organization,” Nature Reviews Genetics, vol. 5, no. 2, pp. 101–113, 2004. View at Publisher · View at Google Scholar · View at Scopus